Artikel
Assessment of psychosocial burden, health-related quality of life and neurocognition in German neurosurgical departments – a survey from the neurooncological section of the DGNC
Wie werden psychosoziale Belastung, gesundheitsbezogene Lebensqualität und Neurokognition in neurochirurgischen Kliniken erfasst? Eine Umfrage der Sektion Neuroonkologie der DGNC
Suche in Medline nach
Autoren
-
Marion Rapp
- Universitätsklinikum Düsseldorf, Neurochirurgie, Düsseldorf, Deutschland
-
Mirjam Renovanz
- Universitätsklinikum Tübingen, Neurochirurgie, Tübingen, Deutschland
-
Dorothee Wiewrodt
- Universitätsklinikum Münster, Neurochirurgie, Münster, Deutschland
-
Carolin Weiß Lucas
- Universitätsklinikum Köln, Neurochirurgie, Köln, Deutschland
| Veröffentlicht: | 26. Juni 2020 |
|---|
Gliederung
Text
Objective: The preservation of health-related quality of life (HRQoL) as well as the assessment and treatment of increased distress are defined therapeutic aims in neurooncological treatment. However, despite the increasing number of certified neurooncological centres, these patient-reported outcomes are not yet part of the regular assessment. Therefore, we aim to develop a standardized assessment approach. In a first step, we perform a survey supported by the neurooncological section of the DGNC to evaluate the status quo. A suggestion for a standard protocol will be developed thereafter.
Methods: We conduct a survey of 140 neurosurgical departments (registered by the DGNC) compromising
- 1.
- the structure of neurooncology,
- 2.
- the personnel infrastructure in the field of psychooncology, palliative care as well as neuropsychology and
- 3.
- applied assessment tools to evaluate psychooncological distress, HRQoL and neurocognition.
Results: So far, data from n=32 surveys (university hospitals (n=19); certified neurooncological centres (n=20)) were included. Three centres refused to participate. HRQoL and psychooncological distress assessment is performed in most departments on a regular basis (n= 18 departments, 56%). HRQoL was mostly assessed using the EORTC-QLQ C30 + BN20 (72%). However, the evaluation of neurooncological distress is quite variable. The following instruments are applied: Distress Thermometer (DT, 66%), Hospital Anxiety and Depression Scale (HADS, 33%), Beck-Depressions-Inventar (BDI, 27%). Neurocognitive assessment is performed mostly in the framework of clinical studies (48%). Only six departments (18%) use at least the Mini Mental Status Test (MMST) on a regular basis.
Conclusion: Our preliminary results reflect that 1) the EORTC-QLQ C30 + BN20 is widely used to evaluate the HRQoL, and 2) there is no consistency in the assessment of distress. Moreover, our data demonstrate that 3) the assessment of neurocognition is only performed sporadically in clinical routine, using poorly sensitive tools.The assessment of patient-reported outcomes is overall poorly standardized across German neurooncological centres. Achieving a common sense regarding a standard protocol seems advisable – not only to encourage the routine assessment of important patient-related parameters in the disease and treatment monitoring but also in order to unify the outcome parameters and thus make study results better comparable.
